New Enterprise Associates related stories
All articles and analysis
CIT GAP Funds backs TypeZeroCIT GAP Funds has made an undisclosed investment in TypeZero Technologies LLC. Based in Charlottesville, Virginia, TypeZero is a medical technology company focused on developing solutions in the management and treatment of Type 1 and Type 2 diabetes.
- HackerOne attracts $25 mln
San Francisco-based cyber security firm HackerOne has secured $25 million in Series B funding, the company announced in a blog post https://hackerone.com/blog/building-security-programs-for-tomorrow on its site. New Enterprise Associates led the round with participation from previous backer Benchmark. In conjunction with the funding, Jon Sakoda, a general partner at NEA, has been added to HackerOne's board of directors.
- Enigma attracts $28.2 mln Series B
Data discovery and analytics provider Engima has received $28.2 million in Series B funding. New Enterprise Associates led the round with participation from Two Sigma Ventures, New York City Investment Fund, American Express Ventures, Comcast Ventures and The New York Times Company.
- IVP, Leonardo DiCaprio, Adam Levine and others back sleep startup Casper
New York City-based mattress maker Casper has raised $55 million in Series B funding. Institutional Venture Partners led the round with participation from other investors that included Leonardo DiCaprio, Tobey Maguire, Adam Levine, Scooter Braun, Pritzker Group Venture Capital, New Enterprise Associates, Lerer Hippeau Ventures and Norwest Venture Partners. In conjunction with the funding, Dennis Phelps of IVP has been named a board observer.
Fundraising recap Jun 20, 2015A summary of recent venture fundraisings and filings worldwide; plus tables on recent fund closings
- Tamr raises $25.2 mln in Series B funding
Data analytics business Tamr, Inc. raised $25.2 million in Series B funding from Hewlett-Packard Ventures, Thomson Reuters, MassMutual Ventures, the corporate venture arm of Massachusetts Mutual Life Insurance Company, Sinewave Ventures and Work-Bench Ventures. Existing investors New Enterprise Associates and Google Ventures also participated in the funding round.
- NEA, Revolution Ventures lead $7.7 mln funding in Framebridge
New Enterprise Associates and Revolution Ventures have led a $7.7 million Series A funding round in Framebridge, an online and mobile custom framing business. Timothy O'Shaughnessy, president of Graham Holdings and former CEO and co-founder of LivingSocial, also participated in the funding. Framebridge has raised more than $11 million to date.
- NEA leads $10 mln round for Philo
Philo said Monday that it raised $10 million in its Series B financing led by New Enterprise Associates. Investors including CBC New Media Group of Raleigh, NC; Home Box Office, Inc. (HBO); Rho Ventures; XFUND; and CEO Andrew McCollum also participated. Cambridge, Massachusetts-based Philo aims to bring live TV and DVR to college students on the devices they own.
NEA pitches in for Derek Jeter's company The Players' TribuneNew Enterprise Associates has led a $9.5 million Series B funding round for The Players’ Tribune, a New York-based media company founded by Derek Jeter and which posts content from athletes. Jeter launched the site last October. Joining NEA in the Series B round are existing investors, including Thomas Tull of Legendary Entertainment. As part of the funding, Jon Sakoda, general partner of NEA, has joined the board.
XTuit nets $22 mln in Series A round with help from CTI Life SciencesU.S. biopharmaceutical company XTuit Pharmaceuticals Inc has received US$22 million in a Series A financing. The round was led by U.S. venture capital firm New Enterprise Associates and joined by founding investor Polaris Partners, as well as new investors, which included Canadian firm CTI Life Sciences. XTuit, which is developing a novel class of therapeutics targeting disease-promoting microenvironment in cancer and fibrotic diseases, said it will use the proceeds of the deal to advance development of its lead products and to build its biomarker platform. In January, CTI secured $134 million in the first close of its second fund /canada/2015/01/15/cti-life-sciences-raises-134-mln-in-first-close-of-fund-ii-boosts-staff/ CTI II.